H.R. 4348 would extend two federal public health programs aimed at tick-borne and other vector-borne diseases. It updates the National Strategy and Regional Centers of Excellence in Vector-Borne Disease under Section 317U of the Public Health Service Act and the health-department support program under Section 2822(c). The bill pushes both programs’ authorization dates from 2021–2025 to 2026–2030. In practical terms, it keeps federal coordination, research, and state and local disease-response support in place for another five years.
What This Bill Does
- Extends Section 317U programs from 2021–2025 to 2026–2030.
- Keeps the National Strategy and Regional Centers of Excellence in Vector-Borne Disease authorized.
- Adds language calling for greater capacity to identify, report, prevent, and respond to these diseases.
- Extends Section 2822(c) support for health departments through 2030.
Who This Bill Affects
For most people, the bill’s effect is indirect: it does not create a new benefit or charge, but it keeps federal tick- and vector-borne disease programs operating through 2030. If you live in an area where Lyme disease or other vector-borne illnesses are common, you may see a concrete benefit from better surveillance, reporting, prevention, and local health-department response. The change is mainly felt through public health agencies, clinicians, and communities that rely on those programs rather than through a direct individual entitlement.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- State and local health departments They would get continued federal backing to track and respond to tick-borne and other vector-borne diseases. The extension helps preserve staffing, surveillance, and outbreak-response capacity instead of forcing programs to wind down when an authorization expires.
- Public health researchers and vector-borne disease experts The bill sustains the national strategy and regional centers that coordinate research and public-health practice. The added language on identifying, reporting, preventing, and responding to disease supports a more operational approach to prevention.
- Patients and families in high-risk regions People in areas with frequent Lyme disease or similar illnesses benefit when health departments can detect trends earlier and educate communities more effectively. Continued federal support can improve access to timely information and response resources.
- Fiscal conservatives focused on limiting federal extensions They may argue the bill simply renews existing programs without changing their scope, and that Congress should justify continued federal spending program by program. A clean extension can be seen as automatic continuation rather than a fresh policy decision.
- Advocates for reallocating public health funds to other priorities Some stakeholders may prefer to redirect limited public health dollars toward broader or more urgent issues, such as hospital preparedness or chronic disease prevention. From that view, extending a specialized vector-borne disease program may crowd out other needs.
- Officials concerned about overlapping federal and state roles They may worry that federal reauthorization can duplicate work already done by state health agencies. Even where the programs are useful, critics could question whether the federal role is larger than necessary.
Key Implications
-
““increasing capacity to identify, report, prevent, and respond””
This makes clear the bill is aimed at practical public-health readiness, not just research. It points toward stronger surveillance and faster local response when cases appear.
-
““2021 through 2025” ... “2026 through 2030””
The bill does not create a brand-new program; it extends existing authority for another five years. That matters because expiring authorizations can disrupt planning, staffing, and grant continuity.
-
““Enhanced Support To Assist Health Departments””
State and local health departments are a central target of the bill. The effect is to keep federal support flowing to the agencies that investigate and manage vector-borne disease cases on the ground.
-
““Regional Centers of Excellence in Vector-Borne Disease””
These centers are intended to help coordinate expertise across regions. For people in endemic areas, that can mean better guidance, research translation, and disease-control capacity.
Official Source & Bill Facts
BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.
- Bill
- HR 4348
- Congress
- 119th Congress
- Official title
- To reauthorize the Kay Hagan Tick Act, and for other purposes.
- Policy area
- Healthcare
- Latest action
- Placed on the Union Calendar, Calendar No. 630. (July 2, 2026)
- Last updated
- July 3, 2026
Latest Status
July 2, 2026
Placed on the Union Calendar, Calendar No. 630.
Related Bills
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.